BullBD Old Apps Site
Home
Details Chart Today news Share news Top gainer Top Looser Upcoming events
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0 1 2 3 4 5 6 7 8 9 All
Bank Cement Ceramics Sector Corporate Bond Engineering Financial Institutions Food & Allied Fuel & Power IT Sector Insurance Jute Life Insurance Miscellaneous Mutual Funds Paper & Printing Pharmaceuticals & Chemicals Services & Real Estate Tannery Industries Telecommunication Textile Travel & Leisure All
  • Details
  • Chart
  • News

IBP

All Eps Dividend Board Agm Q1 Q2 Q3

IBP 25-Jan-2022

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on January 30, 2022 at 3:00 PM to consider, among others, un-audited financial statements of the Company for the Second Quarter (Q2) period ended December 31, 2021.

ঢাকা স্টক এক্সচেঞ্জ (লিস্টিং) রেগুলেশন, 2015-এর রেগুলেশন 16(1) অনুসারে, কোম্পানিটি জানিয়েছে যে 30 জানুয়ারী, 2022 তারিখে বিকাল 3:00 টায় পরিচালনা পর্ষদের একটি সভা অন্যান্যদের মধ্যে বিবেচনা করার জন্য অনুষ্ঠিত হবে, ৩১ ডিসেম্বর, ২০২১ তারিখে শেষ হওয়া দ্বিতীয় ত্রৈমাসিকের (Q2) সময়ের জন্য কোম্পানির অনিরীক্ষিত আর্থিক বিবৃতি।

IBP 16-Nov-2021

(Continuation news of IBP): The Nomination and Remuneration Committee (NRC), of the company that reviewed all post employee benefits and the policies are under process for final review of the Board. Our opinion is not modified in respect of this matter. (end)

IBP 08-Nov-2021

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on November 14, 2021 at 4:00 PM to consider, among others, un-audited financial statements of the Company for the First Quarter (Q1) period ended on September 30, 2021.

IBP 31-Oct-2021

The Board of Directors has recommended 4% Cash dividend (Excluding sponsor and Director) and 3% Stock Dividend for General Shareholders and ICB Excluding sponsors and Directors) for the year ended on June 30, 2021. Sponsors and Directors hold 43.82% share and General shareholders hold 56.17 share and taka 25.56 million will be paid as dividend. Date of AGM: December 13, 2021, Time: 11:30 AM, Venue: Digital Platform. Record Date: November 17, 2021. (Cont.1)

IBP 21-Oct-2021

As per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on October 28, 2021 at 4:00 PM to consider, among others, audited financial statements of the Company for the year ended on June 30, 2021.

IBP 30-Sep-2021

The company has informed the Board of Directors has decided to purchased and executed register sale deed for the purchase of land measuring 1.612 acres as 2nd phase at the cost of Tk. 4,20,68,320.00 (including of registration fee and other relevant cost Tk. 45,07,320.00) situated at Fulbaria, Kaliakoir, Gazipur. The purpose of the land is for future expansion of the business and the amount was paid from the own fund of the company.

IBP 25-Apr-2021

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on April 29, 2021 at 2:00 PM to consider, among others, un-audited financial statements of the Company for the Third Quarter (Q3) period ended on March 31, 2021.

IBP 13-Apr-2021

Referring to their earlier letter no. IBPL/Board secretariat/DSE/news/2021/19 and news disseminated by DSE dated 23.03.2021 regarding suspending the production and marketing of all licensed items of lndo-Bangla Pharmaceuticals Ltd., the Company has informed that the Directorate General of Drug Administration (DGDA) has withdrawn the temporary suspension order of production and marketing of all licensed items by issued memo No. DGDA/ML-032/06/7151 on 12 April 2021.

IBP 24-Jan-2021

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on January 27, 2021 at 4:00 PM to consider, among others, un-audited financial statements of the Company for the Second Quarter (Q2) period ended on December 31, 2020.

IBP 17-Nov-2020

(Continuation news of IBP): Our opinion is not modified in respect of this matter. b) We draw attention to Note 2.20 of the financial statements, which describes that a number of transactions entered into by the company were cash transactions with prior board approval and this was due to suppliers' demand. Our opinion is not modified in respect of this matter. (end)

Previous Next page